Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mesoblast Ltd (NASDAQ:MESO)

7.07
Delayed Data
As of 4:00pm ET
 +0.16 / +2.32%
Today’s Change
4.26
Today|||52-Week Range
16.25
+11.16%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close6.91
Today’s open7.20
Day’s range6.99 - 7.20
Volume42,141
Average volume (3 months)40,803
Market cap$461.5M
Dividend yield--
Data as of 4:00pm ET, 05/31/2016

Growth & Valuation

Earnings growth (last year)-33.20%
Earnings growth (this year)+20.81%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+13.25%
P/E ratio--
Price/Sales54.36
Price/Book0.98

Competitors

 Today’s
change
Today’s
% change
IVCInvacare Corp+0.21+2.00%
CFMSConforMIS Inc+0.14+1.90%
VASCVascular Solutions I...-0.27-0.70%
RTIXRTI Surgical Inc-0.10-2.58%
Data as of 4:02pm ET, 05/31/2016

Financials

Next reporting dateAugust 23, 2016
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$17.1M
Annual profit (last year)-$99.4M
Net profit margin-582.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, Executive Director &
MD
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts

Partner Offers

Search for Jobs